UiPath Inc. (NYSE:PATH) Receives $13.62 Consensus Target Price from Brokerages

Shares of UiPath Inc. (NYSE:PATH - Get Free Report) have received an average recommendation of "Hold" from the nineteen ratings firms that are presently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation, fifteen have given a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $13.62.

A number of equities research analysts have recently weighed in on the stock. Morgan Stanley cut their target price on shares of UiPath from $16.00 to $12.00 and set an "equal weight" rating on the stock in a research note on Thursday, March 13th. Evercore ISI cut their price objective on UiPath from $16.00 to $12.00 and set an "in-line" rating on the stock in a research report on Thursday, March 13th. Barclays decreased their target price on UiPath from $15.00 to $12.00 and set an "equal weight" rating for the company in a research report on Thursday, March 13th. Bank of America reaffirmed an "underperform" rating and issued a $10.00 price target (down from $18.00) on shares of UiPath in a research note on Thursday, March 13th. Finally, UBS Group lowered their price objective on UiPath from $14.00 to $10.00 and set a "sell" rating for the company in a research report on Thursday, March 13th.

UiPath Stock Down 1.9 %

Shares of NYSE PATH traded down $0.21 during midday trading on Tuesday, reaching $10.67. The company had a trading volume of 1,182,162 shares, compared to its average volume of 10,453,160. The firm's fifty day moving average price is $12.94 and its 200-day moving average price is $13.04. The stock has a market cap of $5.86 billion, a PE ratio of -66.67 and a beta of 1.00. UiPath has a one year low of $9.50 and a one year high of $22.83.

Remove Ads

Insider Activity

In related news, CAO Hitesh Ramani sold 25,000 shares of the business's stock in a transaction that occurred on Friday, January 3rd. The stock was sold at an average price of $13.05, for a total transaction of $326,250.00. Following the completion of the transaction, the chief accounting officer now directly owns 269,421 shares in the company, valued at approximately $3,515,944.05. The trade was a 8.49 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Ashim Gupta sold 47,227 shares of the stock in a transaction that occurred on Friday, January 3rd. The stock was sold at an average price of $13.06, for a total transaction of $616,784.62. Following the completion of the sale, the chief financial officer now directly owns 856,538 shares of the company's stock, valued at $11,186,386.28. This represents a 5.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 22.37% of the company's stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC raised its holdings in UiPath by 68.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 160,369 shares of the company's stock valued at $2,038,000 after acquiring an additional 64,900 shares during the period. NorthCrest Asset Manangement LLC bought a new stake in UiPath during the 4th quarter valued at approximately $142,000. American Trust purchased a new position in UiPath in the 4th quarter worth approximately $151,000. Focus Partners Advisor Solutions LLC bought a new position in UiPath in the 4th quarter worth approximately $158,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in UiPath by 39.5% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,401,993 shares of the company's stock valued at $17,819,000 after buying an additional 397,121 shares in the last quarter. Hedge funds and other institutional investors own 62.50% of the company's stock.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.